These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19798812)

  • 1. Interferon beta retinopathy in a patient with multiple sclerosis.
    Post JW; Colleaux K
    Can J Ophthalmol; 2009 Oct; 44(5):e37. PubMed ID: 19798812
    [No Abstract]   [Full Text] [Related]  

  • 2. Exacerbation of Susac syndrome retinopathy by interferon Beta-1a.
    Laird PW; Newman NJ; Yeh S
    Arch Ophthalmol; 2012 Jun; 130(6):804-6. PubMed ID: 22801853
    [No Abstract]   [Full Text] [Related]  

  • 3. [Interferon beta-1b retinopathy during a treatment for multiple sclerosis].
    Sommer S; Sablon JC; Zaoui M; Rozot P; Hosni A
    J Fr Ophtalmol; 2001 May; 24(5):509-12. PubMed ID: 11397988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cotton wool spots associated with interferon beta-1 alpha therapy.
    Longmuir R; Lee AG; Rouleau J
    Semin Ophthalmol; 2007; 22(1):49-53. PubMed ID: 17366120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interferon-beta retinopathy].
    Sallansonnet-Froment M; Roux X; de Greslan T; Bounolleau P; Taillia H; Ricard D; Ouologuem M; Renard JL
    Rev Neurol (Paris); 2009 Nov; 165(11):971-4. PubMed ID: 19147167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinopathy in a multiple sclerosis patient undergoing interferon-therapy.
    Saito H; Suzuki M; Asakawa T; Kato S
    Mult Scler; 2007 Aug; 13(7):939-40. PubMed ID: 17468441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymptomatic peripheral retinal hemorrhages as a manifestation of interferon beta 1a retinopathy.
    Bakri SJ; Swanson JW
    Semin Ophthalmol; 2015 Jan; 30(1):56-7. PubMed ID: 23952180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute hepatitis secondary to interferon beta-1a in multiple sclerosis.
    Christopher V; Scolding N; Przemioslo RT
    J Neurol; 2005 Jul; 252(7):855-6. PubMed ID: 15742101
    [No Abstract]   [Full Text] [Related]  

  • 9. Retinopathy during interferon-β treatment for multiple sclerosis: case report and review of the literature.
    Gaetani L; Menduno PS; Cometa F; Di Gregorio M; Sarchielli P; Cagini C; Calabresi P; Di Filippo M
    J Neurol; 2016 Mar; 263(3):422-7. PubMed ID: 26292794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subacute thyroiditis in a patient with MS treated with interferon beta-1a.
    Kreiss Y; Cohen O; Pras E; Achiron A
    Neurology; 1999 Oct; 53(7):1606. PubMed ID: 10534282
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoimmune hepatitis and interferon beta-1a for multiple sclerosis.
    Duchini A
    Am J Gastroenterol; 2002 Mar; 97(3):767-8. PubMed ID: 11922585
    [No Abstract]   [Full Text] [Related]  

  • 12. Interferon-associated retinopathy and cystoid macular edema.
    Tokai R; Ikeda T; Miyaura T; Sato K
    Arch Ophthalmol; 2001 Jul; 119(7):1077-9. PubMed ID: 11448335
    [No Abstract]   [Full Text] [Related]  

  • 13. [Retinopathy and renal failure in a patient with multiple sclerosis under treatment with beta-interferon].
    Gabaldón Torres L; Aguilar-Amat Prior MJ; Oreja-Guevara C; Díez-Tejedor E
    Med Clin (Barc); 2010 Apr; 134(11):511. PubMed ID: 20137793
    [No Abstract]   [Full Text] [Related]  

  • 14. Vitiligo and multiple sclerosis in a patient treated with interferon beta-1a: a case report.
    Kocer B; Nazliel B; Oztas M; Batur HZ
    Eur J Neurol; 2009 Apr; 16(4):e78-9. PubMed ID: 19222549
    [No Abstract]   [Full Text] [Related]  

  • 15. Recurrent nephrotic syndrome in patient with multiple sclerosis treated with interferon beta-1a.
    Tola MR; Caniatti LM; Gragnaniello D; Russo M; Stabellini N; Granieri E
    J Neurol; 2003 Jun; 250(6):768-9. PubMed ID: 12862038
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic myeloid leukaemia in two multiple sclerosis patients on interferon beta-1a.
    Almeida L; Neves M; Cardoso E; Melo A
    J Clin Pharm Ther; 2009 Feb; 34(1):125-7. PubMed ID: 19125911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lethal capillary leak syndrome after a single administration of interferon beta-1b.
    Niederwieser G
    Neurology; 2000 Apr; 54(7):1545-6. PubMed ID: 10751284
    [No Abstract]   [Full Text] [Related]  

  • 18. Meningioma growth during interferon beta-1A treatment for multiple sclerosis.
    Gama HP; Rocha AJ; Silva CJ; Mendes MF; Veiga JC; Lancellotti CL; Andrade VP; Tilbery CP
    Arq Neuropsiquiatr; 2008 Jun; 66(2B):402-4. PubMed ID: 18641881
    [No Abstract]   [Full Text] [Related]  

  • 19. An open labelled assessment of adverse effects associated with interferon 1-beta in the treatment of multiple sclerosis.
    Ozuma J
    J Neurosci Nurs; 1996 Apr; 28(2):72. PubMed ID: 8718753
    [No Abstract]   [Full Text] [Related]  

  • 20. Local pain during REBIF injection is not due to acidic pH.
    Buttmann M; Goebeler M; Rieckmann P
    J Neurol Neurosurg Psychiatry; 2004 Jul; 75(7):1078. PubMed ID: 15201384
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.